Clinical trial
FST-100 in the Treatment of Acute Adenoviral Conjunctivitis
NCT01470664 · Shire, Industry · Completed
Key facts
| NCT number | NCT01470664 |
|---|---|
| Title | FST-100 in the Treatment of Acute Adenoviral Conjunctivitis |
| Official title | A Proof-of-Concept, Multi-center, Randomized, Double-Masked Study to Evaluate the Clinical Efficacy and Safety of FST-100 Ophthalmic Suspension in the Treatment of Acute Adenoviral Conjunctivitis |
| Lead sponsor | Shire, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Acute Adenoviral Conjunctivitis |
| Intervention type | Drug |
| Interventions | FST-100, FST-100 (Component #1), FST-100 Vehicle |
| Enrollment | 176 |
| Start date | Dec 17, 2012 |
| Primary completion | May 23, 2014 |
| Completion | May 23, 2014 |
| First posted | Nov 11, 2011 |
| Last update posted | Jun 25, 2021 |
| Countries | India, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: